PHARMACEUTICAL MARKET RESEARCH REPORTS
Industry Standard Research – ISR Reports – is a full-service pharmaceutical market research company operating exclusively in the life sciences industry and a sister company of BioProcess Online. Their syndicated and custom market research capabilities enable their customers to make smarter, more informed business decisions. You’ll find links to their pharmaceutical market syndicated research reports below.
ISR's market research reports are produced using direct feedback from decision-makers, which enables ISR to provide data on topics that, until now, were only attainable through custom research. With rigorous screening criteria and methodologies that include surveys, in-depth phone interviews, and focus groups, ISR gathers actionable information that is immediately applicable to their customers. Each report is available for to purchase online and you may also download free preview files. If you have any questions, please feel free to email info@ISRreports.com.
TRENDS AND MARKET OUTLOOKS
Bioprocessing Market Outlook: 2022-2027
This report provides an overview of the current market dynamics for bioprocessing and predictions on its next five years. It also offers insight into the CDMO selection process and the main drivers of sponsor satisfaction on outsourced bioprocessing projects.
Biosimilars Manufacturing: Key Considerations and Expected Outsourcing Practices (4th Edition)
This market research report goes into depth on the manufacturing aspect of biosimilars. Manufacturing these complex products in a cost efficient manner will be a critical component to successfully commercializing biosimilars and the anticipated boom.
Sterile Injectable Drug Product Manufacturing Market Outlook (3rd Ed.)
This report explores which delivery formats drug innovators are using in their pipelines and portfolios, how likely innovators are to outsource manufacturing based on delivery device, and how these proportions will shift over the next five years.
Pharmaceutical Excipient Market Overview and Outlook
This market research report offers readers the opportunity to gain insight into the biopharmaceutical excipient market and where it’s heading. Remaining aware of market dynamics and expected changes will enable readers to better make key decisions regarding excipient use and to help identify where competitive advantages may be gained.
Development vs Commercial Outsourced Manufacturing Practices: Biologics
This market research report explores how the decision-making process differs among drug innovators outsourcing development activities from those outsourcing commercial manufacturing when it comes to CMO/CDMO selection criteria, use patterns, preferences and perceived leadership.
Central Lab Benchmarking & Market Dynamics (2nd Ed.)
This report will help both study sponsors and providers answer a number of questions relevant to selecting and evaluating central lab service providers. For the purpose of this report, “central lab” is defined as a vendor that supplies specimen collection kits, logistics services, safety alerts, and a wide variety of laboratory testing services as well as providing lab reports to investigators.
QUALITY BENCHMARKING AND SERVICE PROVIDER PERFORMANCE
Bioanalytical Labs Market Dynamics and Service Provider Performance
Sponsors can use this report to evaluate their lab selection process. Bioanalytical labs can use it to learn how their company performs against competitors. Topics covered include lab selection and perceptions, lab performance, and lab service quality profiles.
Biologic Drug Product CDMO Benchmarking (5th Ed.)
This report provides pharmaceutical companies and contract manufacturers a comprehensive analysis of current outsourcing trends and practices, in addition to a quantitative analysis of CMO service quality.
Biologic API CDMO Benchmarking For New & Emerging Pharma
This report is based on responses from 45 people involved in outsourced large molecule API projects over the last 18 months. It will help new/emerging pharma companies make informed CDMO selections, and help CDMOs better understand how they are perceived.
DEPARTMENT MODELS AND STRUCTURES
The CMC Function: Best Practices and Optimization
ISR interviewed 15 CMC professionals at 14 Top 50 pharmaceutical and biotechnology companies, as well as one company outside the Top 50 to better understand the Chemistry Manufacturing and Controls function throughout the preclinical, clinical, and commercialization phases of the product development process.
Understanding The Art And Science Of CRO Selection
This e-book examines the rationale behind how CROs are selected, why they are retained, and why sponsors opt for one provider or outsourcing model versus another.
Outsourced Bioprocessing by Respondent Location
Research from ISR finds that a quarter of outsourced bioprocessing efforts are sponsored in America and manufactured in Europe, and vice versa. European respondents report outsourcing slightly more bioprocessing to China on average, while American respondents send more work to Japan and other Asia-Pacific manufacturing facilities (excluding China and India).
Industry Trends: Clinical Logistics Outsourcing
Understanding industry trends, market dynamics, and the selection criteria decision-makers apply when choosing a clinical logistics service provider informs and contextualizes outsourcing decisions.
Use Of Consultants For CDMO Selection
In Q2 2022, ISR asked 99 outsourcers whether the company they work for uses consultants to help guide their CDMO selection process. Read the results from ISR’s CDMO Outsourcing Models (3rd Edition) to gain insight into the use of consultants during CDMO selection.
Biologics Outsourcing Differences By Company Size
ISR split the data from its most recent Biologic API CDMO Benchmarking report by large and non-large respondents to highlight the differences in outsourcing preferences and practices.